Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Pharmaceutical Retailers

PetMed Express, Inc., doing business as 1-800-Petmeds, operates as a pet pharmaceutical company. The Company provides prescription and non-precription pet medications, as well as health and nutritional supplements. PetMed Express offers its products via telephone, fax, mail, and the Internet to customers throughout the United States.
Website: 1800petmeds.com



Growth: Bad revenue growth rate -3.3%, there is slowdown compared to average historical growth rates -1.1%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of -7.2%

Profitability: LTM EBITDA margin is positive, +6.2%. On average the margin is decreasing unsteadily. Gross margin is normal, +25.9%. In the last quarter the company did not beat the estimated EPS. The company was ahead of estimated EPS in 20% of quarters (showing a gain of -$0.16 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 25.1%. Free cash flow yield 5.1% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 1.9% higher than minimum and 89.6% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 1.7x by EV / Sales multiple

Key Financials (Download financials)

Ticker: PETS
Share price, USD:  (-1.0%)4.79
year average price 10.41  


year start price 15.90 2023-03-30

max close price 16.56 2023-04-03

min close price 4.70 2024-03-22

current price 4.79 2024-03-29
Common stocks: 20 301 000

Dividend Yield:  25.1%
FCF Yield LTM: 5.1%
EV / LTM EBITDA: 500.0x
Last revenue growth (y/y):  -3.3%
Last growth of EBITDA (y/y):  ---
Historical revenue growth:  -1.1%
Historical growth of EBITDA:  -16.3%
EV / Sales: -0.0x
Margin (EBITDA LTM / Revenue): 6.2%
Fundamental value created in LTM:
Market Cap ($m): 97
Net Debt ($m): -102
EV (Enterprise Value): -5
Price to Book: 0.9x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-02-08Seeking Alpha

PetMed Express, Inc. (PETS) Q3 2024 Earnings Call Transcript

2023-10-31Market Watch

PetMed's stock plunges to 19-year low as dividend yield to drop from 19% to zero

2023-10-30Zacks Investment Research

PetMed (PETS) Reports Break-Even Earnings for Q2

2023-10-02Seeking Alpha

PetMed Express Still A 'Sell,' But There Are Hopes For A Turnaround

2023-09-07GlobeNewsWire

PetMed Express Announces Upcoming Conference Participation

2023-08-02MarketBeat

PetMed Express: A Stock To Watch For A Potential Turnaround

2023-07-31Seeking Alpha

PetMed Express, Inc. (PETS) Q1 2024 Earnings Call Transcript

2023-07-31Zacks Investment Research

PetMed (PETS) Reports Break-Even Earnings for Q1

2023-07-21Seeking Alpha

PetMed Express: I'd Take That Medicine (Rating Upgrade)

2023-06-01GlobeNewsWire

PetMed Express to Present at the RBC Capital Markets Consumer Day
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol PETS PETS PETS PETS PETS
reportedCurrency USD USD USD USD USD
cik 1M 1M 1M 1M 1M
fillingDate 2023-10-31 2023-08-02 2023-05-23 2023-02-07 2022-11-08
acceptedDate 2023-10-31 16:27:59 2023-08-01 18:17:24 2023-05-23 08:40:26 2023-02-07 17:26:15 2022-11-08 08:54:07
calendarYear 2024.000 2024.000 2023.000 2023.000 2023.000
period Q2 Q1 Q4 Q3 Q2
revenue 71M 78M 62M 59M 65M
costOfRevenue 51M 56M 45M 44M 47M
grossProfit 20M 23M 17M 15M 18M
grossProfitRatio 0.283 0.288 0.279 0.259 0.282
researchAndDevelopmentExpenses 0 0 0 0 0
generalAndAdministrativeExpenses 13M 16M 19M 10M 11M
sellingAndMarketingExpenses 6M 7M 5M 5M 4M
sellingGeneralAndAdministrativeExpenses 19M 23M 24M 15M 15M
otherExpenses 254 000 506 000 994 000 941 000 858 000
operatingExpenses 21M 25M 24M 16M 15M
costAndExpenses 71M 80M 70M 60M 62M
interestIncome 570 000 620 000 857 000 708 000 388 000
interestExpense 0 0 -1M 708 000 388 000
depreciationAndAmortization 2M 2M 994 000 941 000 858 000
ebitda 1M -450 000 -6M 172 000 4M
ebitdaratio 0.018 -0.006 -0.098 0.003 0.058
operatingIncome -441 000 -2M -7M -769 000 3M
operatingIncomeRatio -0.006 -0.027 -0.114 -0.013 0.045
totalOtherIncomeExpensesNet 254 000 506 000 1M 967 000 649 000
incomeBeforeTax 383 000 -1M -6M 198 000 4M
incomeBeforeTaxRatio 0.005 -0.013 -0.097 0.003 0.055
incomeTaxExpense 453 000 -115 000 -927 000 217 000 1M
netIncome -70 000 -887 000 -5M -19 000 3M
netIncomeRatio -0.001 -0.011 -0.082 -0.000 0.039
eps -0.003 -0.044 -0.250 -0.001 0.130
epsdiluted -0.003 -0.044 -0.250 -0.001 0.130
weightedAverageShsOut 20M 20M 20M 20M 20M
weightedAverageShsOutDil 20M 20M 20M 20M 20M
link Link Link Link Link Link
finalLink Link Link Link Link Link

Balance Sheet Statement

Property 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol PETS PETS PETS PETS PETS
reportedCurrency USD USD USD USD USD
cik 1M 1M 1M 1M 1M
fillingDate 2023-10-31 2023-08-02 2023-05-23 2023-02-07 2022-11-08
acceptedDate 2023-10-31 16:27:59 2023-08-01 18:17:24 2023-05-23 08:40:26 2023-02-07 17:26:15 2022-11-08 08:54:07
calendarYear 2024.000 2024.000 2023.000 2023.000 2023.000
period Q2 Q1 Q4 Q3 Q2
cashAndCashEquivalents 53M 62M 104M 102M 97M
shortTermInvestments 0 0 0 0 0
cashAndShortTermInvestments 53M 62M 104M 102M 97M
netReceivables 2M 2M 2M 2M 2M
inventory 19M 32M 19M 22M 34M
otherCurrentAssets 10M 9M 5M 6M 6M
totalCurrentAssets 86M 106M 131M 134M 138M
propertyPlantEquipmentNet 29M 29M 26M 25M 25M
goodwill 22M 21M 0 5M 0
intangibleAssets 17M 18M 6M 860 000 0
goodwillAndIntangibleAssets 40M 38M 6M 6M 6M
longTermInvestments 5M 5M 0 5M 0
taxAssets 5M 7M 628 000 0 0
otherNonCurrentAssets -5M -5M 0 -5M 0
totalNonCurrentAssets 74M 75M 33M 31M 31M
otherAssets 0 0 0 0 0
totalAssets 159M 181M 164M 165M 169M
accountPayables 25M 40M 25M 24M 24M
shortTermDebt 757 000 799 000 0 0 0
taxPayables 1M 2M 2M 839 000 595 000
deferredRevenue 4M 3M 0 -471 000 -389 000
otherCurrentLiabilities 11M 13M 11M 7M 7M
totalCurrentLiabilities 41M 57M 36M 31M 31M
longTermDebt 1M 1M 0 0 0
deferredRevenueNonCurrent 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 465 000 547 000
otherNonCurrentLiabilities 4M 4M 4M 0 -23M
totalNonCurrentLiabilities 5M 5M 4M 465 000 547 000
otherLiabilities 0 0 0 0 0
capitalLeaseObligations 2M 2M 0 0 0
totalLiabilities 46M 62M 40M 32M 31M
preferredStock 9000.000 9000.000 9000.000 9000.000 9000.000
commonStock 21 000 21 000 21 000 21 000 21 000
retainedEarnings 92M 98M 105M 117M 123M
accumulatedOtherComprehensiveIncomeLoss -9000.000 -9000.000 0 0 0
othertotalStockholdersEquity 22M 20M 18M 17M 15M
totalStockholdersEquity 114M 118M 124M 134M 138M
totalEquity 114M 118M 124M 134M 138M
totalLiabilitiesAndStockholdersEquity 159M 181M 164M 165M 169M
minorityInterest 0 0 0 0 0
totalLiabilitiesAndTotalEquity 159M 181M 164M 165M 169M
totalInvestments 5M 5M 0 5M 0
totalDebt 2M 2M 0 0 0
netDebt -52M -59M -104M -102M -97M
link Link Link Link Link Link
finalLink Link Link Link Link Link

Cash Flow Statement

Property 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol PETS PETS PETS PETS PETS
reportedCurrency USD USD USD USD USD
cik 1M 1M 1M 1M 1M
fillingDate 2023-10-31 2023-08-02 2023-05-23 2023-02-07 2022-11-08
acceptedDate 2023-10-31 16:27:59 2023-08-01 18:17:24 2023-05-23 08:40:26 2023-02-07 17:26:15 2022-11-08 08:54:07
calendarYear 2024.000 2024.000 2023.000 2023.000 2023.000
period Q2 Q1 Q4 Q3 Q2
netIncome -70 000 -887 000 -5M -19 000 3M
depreciationAndAmortization 2M 2M 994 000 941 000 858 000
deferredIncomeTax 369 000 -450 000 -1M -82 000 -95 000
stockBasedCompensation 2M 2M 2M 2M 2M
changeInWorkingCapital -5M -2M 13M 10M -6M
accountsReceivables -299 000 -46 000 283 000 -581 000 171 000
inventory 13M -10M 3M 12M -11M
accountsPayables -15M 9M 891 000 337 000 7M
otherWorkingCapital -3M -442 000 9M -1M -2M
otherNonCashItems 17 000 19 000 -78 000 226 000 21 000
netCashProvidedByOperatingActivities -777 000 562 000 10M 13M -1M
investmentsInPropertyPlantAndEquipment -984 000 -1M -2M -993 000 -1M
acquisitionsNet 0 -36M 10M -5M 0
purchasesOfInvestments 0 0 5M -5M 0
salesMaturitiesOfInvestments 0 0 0 0 0
otherInvestingActivites 0 0 -15M 10M 0
netCashUsedForInvestingActivites -984 000 -37M -2M -993 000 -1M
debtRepayment 0 0 0 0 0
commonStockIssued 0 0 0 0 0
commonStockRepurchased 0 0 0 0 0
dividendsPaid -6M -6M -6M -6M -6M
otherFinancingActivites 0 0 0 0 0
netCashUsedProvidedByFinancingActivities -6M -6M -6M -6M -6M
effectOfForexChangesOnCash 0 0 0 0 0
netChangeInCash -8M -43M 2M 6M -9M
cashAtEndOfPeriod 53M 62M 104M 102M 97M
cashAtBeginningOfPeriod 62M 104M 102M 97M 105M
operatingCashFlow -777 000 562 000 10M 13M -1M
capitalExpenditure -984 000 -1M -2M -993 000 -1M
freeCashFlow -2M -591 000 8M 12M -3M
link Link Link Link Link Link
finalLink Link Link Link Link Link

Earning call transcript

2023 q4
2024-02-08 ET (fiscal 2024 q3)
2023 q3
2023-10-30 ET (fiscal 2024 q2)
2023 q2
2023-07-31 ET (fiscal 2024 q1)
2023 q1
2023-05-22 ET (fiscal 2023 q4)
2022 q4
2023-05-24 ET (fiscal 2023 q3)
2022 q3
2023-05-24 ET (fiscal 2023 q2)
2022 q2
2023-05-24 ET (fiscal 2023 q1)
2021 q4
2023-02-06 ET (fiscal 2022 q3)
2021 q3
2021-10-25 ET (fiscal 2022 q2)
2021 q2
2022-07-25 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-02-08 21:01 ET
PetMeds® Announces Selected Preliminary Third Quarter Financial Results
2024-01-29 13:30 ET
PetMed Express, Inc. Sets Fiscal Third Quarter 2024 Earnings Call
2024-01-08 22:46 ET
PetMeds® Announces new Chairman of the Board
2023-11-27 17:26 ET
Both Pets and Pet Parents Feel the Strain of Separation Anxiety When Apart, According to a New Survey from PetMeds®
2023-11-13 15:40 ET
PetMeds® Announces the Formation of Veterinarian Advisory Board
2023-10-30 20:01 ET
PetMeds® Announces Its Second Quarter Financial Results
2023-10-19 12:30 ET
PetMed Express, Inc. Sets Fiscal Second Quarter 2024 Earnings Call
2023-10-12 22:20 ET
PetMeds® Teams Up with Pumpkin® to Help Make Pet Care Simple and Affordable
2023-09-07 20:01 ET
PetMed Express Announces Upcoming Conference Participation
2023-07-31 20:01 ET
PetMeds® Announces Its First Quarter Financial Results and Declares a Quarterly Dividend of $0.30 Per Share
2023-07-17 12:30 ET
PetMed Express, Inc. Sets Fiscal First Quarter 2024 Earnings Call
2023-06-01 12:30 ET
PetMed Express to Present at the RBC Capital Markets Consumer Day
2023-05-22 20:01 ET
PetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results and Declares a Quarterly Dividend of $0.30 Per Share
2023-05-18 20:01 ET
PetMeds® Appoints Sandra Y. Campos to its Board of Directors
2023-05-08 20:01 ET
PetMed Express, Inc. Sets Fourth Quarter and Full Year 2023 Earnings Call
2023-04-03 13:00 ET
PetMeds® Completes Acquisition of PetCareRx
2023-02-06 21:01 ET
PetMeds® Announces Its Third Quarter Financial Results and Declares a Quarterly Dividend of $0.30 Per Share
2023-01-23 21:30 ET
PetMed Express, Inc. Sets Third Quarter 2022 Earnings Call
2023-01-17 13:30 ET
PetMeds® to Acquire PetCareRx
2022-11-07 21:01 ET
PetMeds® Announces Its Second Quarter Financial Results and Declares a Quarterly Dividend of $0.30 Per Share
2022-10-20 13:00 ET
PetMed Express, Inc. Sets Second Quarter 2022 Earnings Call
2022-07-25 20:00 ET
PetMeds® Announces Its First Quarter Financial Results and Declares a Quarterly Dividend of $0.30 Per Share
2022-07-18 12:00 ET
PetMeds® Hires Christine Chambers as Chief Financial Officer
2022-07-11 20:00 ET
PetMeds® To Announce Its First Quarter Financial Results On July 25, 2022
2022-05-09 20:00 ET
PetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results and Declares a Quarterly Dividend of $0.30 Per Share
2022-05-09 12:00 ET
PetMeds® Hires Pet-Industry Veteran into Pivotal Leadership Role
2022-05-02 20:00 ET
PetMeds® To Announce Its Fourth Quarter Financial Results On May 9, 2022
2022-04-19 12:10 ET
Vetster Takes Pet Telehealth Mainstream With $30M USD Series B
2022-04-19 12:05 ET
PetMeds® Announces Exclusive Partnership with Vetster for Pet Telemedicine
2022-03-28 12:00 ET
PetMed Express Welcomes Diana Garvis Purcel to Its Board of Directors
2022-01-24 21:00 ET
PetMeds® Announces Its Third Fiscal Quarter Financial Results and Its Quarterly Dividend of $0.30 Per Share
2022-01-18 13:00 ET
PetMeds® To Announce Its Third Quarter Financial Results On January 24, 2022
2022-01-10 13:00 ET
PetMeds® Appoints Three New Key Executives
2021-10-25 20:00 ET
PetMed Express Announces Its Second Fiscal Quarter Financial Results and Its Quarterly Dividend of $0.30 Per Share
2021-10-18 12:00 ET
PetMed Express To Announce Its Second Quarter Financial Results on October 25, 2021
2021-08-31 12:00 ET
PetMed Express Appoints Matt Hulett, Former Rosetta Stone President, as CEO & President, and Member of the Board of Directors
2021-08-02 12:00 ET
PetMed Express Welcomes Jodi Watson and Peter Cobb to Its Board of Directors
2021-07-26 12:00 ET
PetMed Express, Inc. d/b/a 1-800-PetMeds Announces Its First Quarter Financial Results and a Quarterly Dividend of $0.30 Per Share
2021-07-19 12:00 ET
PetMed Express d/b/a 1-800-PetMeds to Announce Its First Quarter Financial Results on July 26, 2021
2021-05-03 12:00 ET
PetMed Express, Inc. d/b/a 1-800-PetMeds Announces Its Fourth Quarter and Fiscal Year End Financial Results and Increases Its Quarterly Dividend to $0.30 per Share
2021-04-26 12:00 ET
PetMed Express d/b/a 1-800-PetMeds to Announce Its Fiscal Year End Financial Results on May 3, 2021
2021-01-19 13:00 ET
PetMed Express d/b/a 1-800-PetMeds Announces Its Third Fiscal Quarter Financial Results and Its Quarterly Dividend of $0.28 Per Share
2021-01-12 13:00 ET
PetMed Express d/b/a 1-800-PetMeds to Announce Its Third Quarter Financial Results on January 19, 2021
2020-10-26 12:00 ET
PetMed Express d/b/a 1-800-PetMeds Announces Its Second Fiscal Quarter Financial Results and Its Quarterly Dividend of $0.28 per Share
2020-10-19 12:00 ET
PetMed Express D/B/A 1-800-PetMeds To Announce Its Second Quarter Financial Results On October 26, 2020
2020-07-20 12:00 ET
PetMed Express d/b/a 1-800-PetMeds Announces Its Record First Quarter Financial Results
2020-07-13 12:00 ET
PetMed Express d/b/a 1-800-PetMeds to Announce Its First Quarter Financial Results on July 20, 2020
2020-05-04 12:00 ET
PetMed Express, Inc. d/b/a 1-800-PetMeds Announces Its Fourth Quarter and Fiscal Year End Financial Results and Increases Its Quarterly Dividend to $0.28 per Share
2020-04-27 12:00 ET
PetMed Express d/b/a 1-800-PetMeds to Announce Its Fiscal Year End Financial Results on May 4, 2020
2020-01-21 13:00 ET
PetMed Express d/b/a 1-800-PetMeds Announces Its Third Fiscal Quarter Financial Results and Its Quarterly Dividend of $0.27 Per Share
2020-01-14 13:00 ET
PetMed Express d/b/a 1-800-PetMeds to Announce its Third Quarter Financial Results on January 21, 2020

SEC forms

Show financial reports only

SEC form 8
2024-02-08 00:00 ET
PetMed Express published news for 2023 q4
SEC form 8
2024-02-08 00:00 ET
PetMed Express published news for 2023 q4
SEC form 10
2023-10-31 16:27 ET
PetMed Express reported for 2023 q3
SEC form 10
2023-10-31 00:00 ET
PetMed Express reported for 2023 q3
SEC form 8
2023-10-30 16:05 ET
PetMed Express reported for 2023 q3
SEC form 10
2023-08-02 00:00 ET
PetMed Express reported for 2023 q2
SEC form 6
2023-07-31 16:03 ET
PetMed Express reported for 2023 q2
SEC form 8
2023-07-31 00:00 ET
PetMed Express reported for 2023 q2
SEC form 6
2023-06-20 14:16 ET
PetMed Express published news for 2023 q1
SEC form 6
2023-06-20 10:34 ET
PetMed Express published news for 2023 q1
SEC form 8
2023-05-26 00:00 ET
PetMed Express published news for 2023 q1
SEC form 10
2023-05-23 08:40 ET
PetMed Express reported for 2023 q1
SEC form 10
2023-05-23 00:00 ET
PetMed Express reported for 2023 q1
SEC form 6
2023-05-22 16:06 ET
PetMed Express reported for 2023 q1
SEC form 8
2023-05-22 00:00 ET
PetMed Express reported for 2023 q1
SEC form 6
2023-05-18 21:50 ET
PetMed Express published news for 2023 q1
SEC form 6
2023-04-03 14:14 ET
PetMed Express published news for 2023 q1
SEC form 6
2023-02-07 17:57 ET
PetMed Express published news for 2022 q4
SEC form 10
2023-02-07 17:26 ET
PetMed Express reported for 2022 q4
SEC form 10
2023-02-07 00:00 ET
PetMed Express reported for 2022 q4
SEC form 6
2023-02-06 16:03 ET
PetMed Express published news for 2022 q4
SEC form 8
2023-02-06 00:00 ET
PetMed Express reported for 2022 q4
SEC form 6
2023-01-19 09:06 ET
PetMed Express published news for 2022 q4
SEC form 6
2023-01-17 15:00 ET
PetMed Express published news for 2022 q4
SEC form 10
2022-11-08 08:54 ET
PetMed Express reported for 2022 q3
SEC form 10
2022-11-08 00:00 ET
PetMed Express reported for 2022 q3
SEC form 6
2022-11-07 16:05 ET
PetMed Express published news for 2022 q3
SEC form 8
2022-11-07 00:00 ET
PetMed Express reported for 2022 q3
SEC form 6
2022-08-03 16:20 ET
PetMed Express published news for 2022 q2
SEC form 6
2022-08-02 13:36 ET
PetMed Express published news for 2022 q2
SEC form 10
2022-08-02 10:44 ET
PetMed Express reported for 2022 q2
SEC form 10
2022-08-02 00:00 ET
PetMed Express reported for 2022 q2
SEC form 6
2022-07-29 15:57 ET
PetMed Express published news for 2022 q2
SEC form 6
2022-07-27 15:04 ET
PetMed Express published news for 2022 q2
SEC form 8
2022-07-27 00:00 ET
PetMed Express published news for 2022 q2
SEC form 6
2022-07-26 13:14 ET
PetMed Express published news for 2022 q2
SEC form 8
2022-07-26 00:00 ET
PetMed Express reported for 2022 q2
SEC form 6
2022-07-18 08:29 ET
PetMed Express published news for 2022 q2
SEC form 6
2022-07-14 16:06 ET
PetMed Express published news for 2022 q2
SEC form 6
2022-07-11 16:12 ET
PetMed Express published news for 2022 q2
SEC form 6
2022-06-17 15:16 ET
PetMed Express published news for 2022 q1
SEC form 10
2022-05-24 17:23 ET
PetMed Express reported for 2022 q1
SEC form 10
2022-05-24 00:00 ET
PetMed Express reported for 2022 q1
SEC form 6
2022-05-12 10:14 ET
PetMed Express published news for 2022 q1
SEC form 8
2022-05-12 00:00 ET
PetMed Express published news for 2022 q1
SEC form 6
2022-05-10 15:33 ET
PetMed Express published news for 2022 q1
SEC form 6
2022-05-10 12:37 ET
PetMed Express published news for 2022 q1
SEC form 8
2022-05-10 00:00 ET
PetMed Express reported for 2022 q1
SEC form 6
2022-05-03 08:12 ET
PetMed Express published news for 2022 q1
SEC form 6
2022-04-19 10:01 ET
PetMed Express published news for 2022 q1
SEC form 6
2022-03-28 09:44 ET
PetMed Express published news for 2021 q4
SEC form 10
2022-02-04 15:06 ET
PetMed Express published news for 2021 q4
SEC form 10
2022-02-04 00:00 ET
PetMed Express published news for 2021 q4
SEC form 8
2022-01-27 00:00 ET
PetMed Express published news for 2021 q4
SEC form 6
2022-01-26 18:27 ET
PetMed Express published news for 2021 q4
SEC form 6
2022-01-25 15:07 ET
PetMed Express published news for 2021 q4
SEC form 8
2022-01-25 00:00 ET
PetMed Express published news for 2021 q4
SEC form 6
2022-01-18 10:31 ET
PetMed Express published news for 2021 q4
SEC form 6
2022-01-11 12:46 ET
PetMed Express published news for 2021 q4
SEC form 10
2021-11-02 14:39 ET
PetMed Express published news for 2021 q3
SEC form 10
2021-11-02 00:00 ET
PetMed Express published news for 2021 q3
SEC form 6
2021-10-27 11:09 ET
PetMed Express published news for 2021 q3
SEC form 8
2021-10-27 00:00 ET
PetMed Express published news for 2021 q3
SEC form 6
2021-10-26 14:08 ET
PetMed Express published news for 2021 q3
SEC form 6
2021-10-18 14:58 ET
PetMed Express published news for 2021 q3
SEC form 6
2021-08-30 08:01 ET
PetMed Express published news for 2021 q2
SEC form 6
2021-08-03 17:31 ET
PetMed Express published news for 2021 q2
SEC form 6
2021-08-03 17:06 ET
PetMed Express published news for 2021 q2
SEC form 10
2021-07-30 12:01 ET
PetMed Express published news for 2021 q2
SEC form 10
2021-07-30 00:00 ET
PetMed Express published news for 2021 q2
SEC form 6
2021-07-27 11:24 ET
PetMed Express published news for 2021 q2
SEC form 8
2021-07-27 00:00 ET
PetMed Express published news for 2021 q2
SEC form 6
2021-07-26 15:58 ET
PetMed Express published news for 2021 q2
SEC form 6
2021-07-20 09:48 ET
PetMed Express published news for 2021 q2
SEC form 6
2021-07-06 14:18 ET
PetMed Express published news for 2021 q2
SEC form 6
2021-06-17 17:27 ET
PetMed Express published news for 2021 q1
SEC form 6
2021-06-15 11:52 ET
PetMed Express published news for 2021 q1
SEC form 6
2021-06-04 16:35 ET
PetMed Express published news for 2021 q1
SEC form 6
2021-05-26 17:56 ET
PetMed Express published news for 2021 q1
SEC form 10
2021-05-25 07:35 ET
PetMed Express published news for 2021 q1
SEC form 10
2021-05-25 00:00 ET
PetMed Express published news for 2021 q1
SEC form 6
2021-05-05 14:56 ET
PetMed Express published news for 2021 q1
SEC form 8
2021-05-05 00:00 ET
PetMed Express published news for 2021 q1
SEC form 6
2021-05-04 11:31 ET
PetMed Express published news for 2021 q1
SEC form 6
2021-04-26 14:26 ET
PetMed Express published news for 2021 q1
SEC form 6
2021-02-24 15:07 ET
PetMed Express published news for 2020 q4
SEC form 6
2021-02-18 16:39 ET
PetMed Express published news for 2020 q4
SEC form 6
2021-02-16 16:50 ET
PetMed Express published news for 2020 q4
SEC form 10
2021-01-26 12:00 ET
PetMed Express published news for 2020 q4
SEC form 6
2021-01-20 16:49 ET
PetMed Express published news for 2020 q4
SEC form 6
2021-01-20 12:19 ET
PetMed Express published news for 2020 q4
SEC form 6
2021-01-13 10:39 ET
PetMed Express published news for 2020 q4
SEC form 10
2020-11-03 15:22 ET
PetMed Express published news for 2020 q3
SEC form 6
2020-10-28 12:39 ET
PetMed Express published news for 2020 q3
SEC form 6
2020-10-26 15:55 ET
PetMed Express published news for 2020 q3
SEC form 6
2020-10-19 16:31 ET
PetMed Express published news for 2020 q3